Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed interventional clinical trials eagerly awaited
@article{TLCR71769, author = {Marc G. Denis and Guillaume Herbreteau and Elvire Pons-Tostivint}, title = {Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed interventional clinical trials eagerly awaited}, journal = {Translational Lung Cancer Research}, volume = {12}, number = {2}, year = {2023}, keywords = {}, abstract = {}, issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/71769} }